Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00999
|
|||||
Drug Name |
Diazepam
|
|||||
Synonyms |
Diazepam (intranasal, epilepsy); 439-14-5; Amiprol; Ansiolin; Ansiolisina; Apaurin; Apozepam; Assival; Atensine; Atilen; Bensedin; Bialzepam; Calmocitene; Calmpose; Ceregulart; Condition; Diacepan; Diapam; Diazemuls; Diazepan; Diazetard; Dipezona; Domalium; Faustan; Kiatrium; Levium; Liberetas; Methyldiazepinone; Neurolytril; Paranten; Quetinil; Quiatril; Quievita; Relaminal; Relanium; Renborin; Ruhsitus; Sedipam; Seduksen; Seduxen; Serenack; Serenamin; Serenzin; Sibazon; Sonacon; Stesolid; Stesolin; Tensopam; Tranimul; Tranqdyn; Tranquirit; Umbrium; Unisedil; Valitran; Valium; diazepam
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Anxiety [ICD11: MB24.3] | Approved | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C16H13ClN2O
|
|||||
Canonical SMILES |
CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
|
|||||
InChI |
InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3
|
|||||
InChIKey |
AAOVKJBEBIDNHE-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 439-14-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 284.74 | Topological Polar Surface Area | 32.7 | ||
Heavy Atom Count | 20 | Rotatable Bond Count | 1 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
XLogP |
3
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:49575
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | P-GP | Transporter Info | Km = 72.4 microM | High five cells-MDR1 | [2] | |
References | ||||||
1 | Diazepam was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Pharm Res. 2001 Dec;18(12):1660-8. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.